MEG3 and breast cancer: The results revealed that some circulating lncRNAs (MEG3, NBAT1, NKILA, GAS5, EPB41L4A‐AS2, Z38, and BC040587) were significantly down‐regulated in breast cancer patients compared to healthy women.